Travelling To India for Eye Care

Travelling to India for eye treatment? Travel for medical care is not simply about finding treatment. It is about finding the right diagnosis, understanding your options, and making important decisions with confidence. Dr Shibal Bhartiya provides specialist eye care for international patients seeking expert evaluation, second opinions, advanced diagnostics, and long-term management of complex eye conditions.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Expert Eye Care in India for Patients Seeking Clarity, Confidence, and Specialist Opinion

GlaucomaNeuro-OphthalmologyDry Eye & Ocular Surface DiseaseComplex Eye Care

Patients travel from the UK, USA, UAE, Singapore, Bangladesh, Nepal, East Africa, and across South Asia for consultations focused on careful assessment, evidence-based recommendations, and clear communication.

25+ Years Experience | 200+ Publications | 28 Textbooks | 1,500+ Five-Star Reviews | International Patients from 20+ Countries | 40000+ patients


Why International Patients Choose Dr Shibal Bhartiya

A Specialist Perspective for Complex Problems

Many patients seeking international consultations are not looking for another routine eye examination.

They are seeking answers to questions such as:

  • Am I actually progressing?
  • Do I really need surgery?
  • Why do my symptoms not match my test results?
  • Has something important been missed?
  • Why am I still struggling despite treatment?
  • Should I seek a second opinion before making a major decision?

Our consultations are designed to answer these questions through detailed evaluation, advanced diagnostics, and careful clinical interpretation.


Areas of Special Expertise

Glaucoma

Glaucoma is often diagnosed late because patients may continue seeing well while irreversible damage accumulates silently.

Dr Bhartiya’s glaucoma practice focuses on:

  • Early glaucoma diagnosis
  • Glaucoma suspects and risk assessment
  • Progression analysis
  • Normal tension glaucoma
  • Complex glaucoma management
  • Surgical decision-making
  • Second opinions before surgery
  • Long-term vision preservation strategies

Many international patients seek consultation after receiving conflicting advice or when they are uncertain whether treatment escalation is truly necessary.

You can read more about glaucoma here


Neuro-Ophthalmology

Neuro-ophthalmology bridges the gap between ophthalmology and neurology.

Common reasons for referral include:

  • Optic nerve disorders
  • Unexplained visual loss
  • Visual field abnormalities
  • Pituitary-related visual problems
  • Double vision
  • Intracranial hypertension
  • Neurological causes of visual symptoms
  • Complex diagnostic uncertainty

Patients are often referred after multiple consultations when symptoms, scans, and examinations do not fit together neatly.

You can read more about neuro-ophthalmology care here


Dry Eye & Ocular Surface Disease

Many patients with ocular surface disease have been treated repeatedly without understanding the underlying drivers of their symptoms.

Areas of focus include:

  • Chronic dry eye disease
  • Meibomian gland dysfunction
  • Ocular surface inflammation
  • Computer-related eye strain
  • Autoimmune ocular surface disease
  • Refractory dry eye
  • Ocular GVHD
  • Complex ocular discomfort syndromes

The goal is not simply prescribing more drops, but understanding why symptoms persist.

You can read more about ocular surface diseases including dry eye, and allergies, here


Comprehensive Ophthalmology & Diagnostic Second Opinions

Not every patient arrives with a diagnosis.

Many simply know that something is wrong.

We frequently evaluate patients seeking answers regarding:

  • Unexplained visual symptoms
  • Diagnostic uncertainty
  • Cataract and glaucoma overlap
  • Complex treatment decisions
  • Risk assessment before intervention
  • Long-term monitoring plans

Explore Our Specialist Eye Care Services

International patients often arrive with a diagnosis, a recommendation, or simply a concern that something is being missed.

While glaucoma, neuro-ophthalmology, and ocular surface disease are areas of particular expertise, every patient journey is different. Explore our specialist services below to better understand your condition and the options available.

Glaucoma Care

Glaucoma can cause permanent vision loss before symptoms become obvious. Learn about glaucoma diagnosis, risk assessment, progression monitoring, treatment options, and specialist second opinions.

Explore Glaucoma Care →


Neuro-Ophthalmology

Visual symptoms are not always caused by the eye itself. Neuro-ophthalmology evaluates disorders affecting the optic nerve, visual pathways, eye movements, and the connection between the eye and brain.

Explore Neuro-Ophthalmology →


Dry Eye & Ocular Surface Disease

Persistent irritation, burning, watering, fluctuating vision, and discomfort often require a deeper evaluation than routine eye examinations provide. Learn more about dry eye disease, meibomian gland dysfunction, ocular GVHD, and ocular surface disorders.

Explore Dry Eye & Ocular Surface Disease →


Second Opinions

Many patients seek reassurance before surgery, treatment escalation, or major decisions. A specialist second opinion can provide clarity, confirm a diagnosis, or identify alternative approaches.

Explore Second Opinions →


Advanced Diagnostic Testing

Accurate diagnosis depends on more than a single test result. Learn how OCT imaging, visual field analysis, optic nerve evaluation, and ocular surface assessment contribute to clinical decision-making.

Explore Advanced Diagnostics →


Comprehensive Eye Care

Not every patient arrives with a diagnosis. Some simply know that their vision has changed or that something does not feel right. Explore common eye conditions, symptoms, and specialist evaluation pathways.

Explore Comprehensive Eye Care →

Whether you are seeking a second opinion, treatment recommendations, or answers to a complex diagnostic question, our goal is to help you understand your condition clearly and make confident decisions about your eye health.

Popular Searches: glaucoma specialist India, neuro-ophthalmologist India, dry eye specialist India, glaucoma second opinion India, ocular surface disease specialist India, international eye specialist India, advanced eye care India, ophthalmologist for international patients.


International Patient Journey

Step 1: Send Your Records

Before travelling, patients may share:

  • Previous consultation notes
  • OCT scans
  • Visual field reports
  • MRI or CT reports
  • Surgical recommendations
  • Current medication lists

This allows preliminary review and helps ensure efficient use of consultation time.


Step 2: Pre-Visit Review

Records are reviewed before your appointment whenever possible.

This means consultations begin with context rather than starting from zero.


Step 3: Specialist Evaluation

Consultations may include:

  • Comprehensive examination
  • Advanced imaging
  • Functional testing
  • Risk assessment
  • Discussion of treatment options
  • Clarification of previous findings

Most investigations can be completed in a single visit.


Step 4: Written Clinical Opinion

Patients receive:

  • Detailed findings
  • Interpretation of investigations
  • Diagnosis (where possible)
  • Treatment recommendations
  • Follow-up strategy

Reports can be shared with treating doctors in the patient’s home country to support continuity of care.


Step 5: Ongoing Follow-Up

Many eye conditions require continuity rather than isolated intervention.

Where appropriate, follow-up planning may include:

  • Remote review of reports
  • Communication with local specialists
  • Monitoring recommendations
  • Long-term management planning

Why Patients Travel to India

India offers access to:

  • Advanced ophthalmic diagnostics
  • Internationally recognised specialists
  • Minimal waiting times
  • Comprehensive investigations in one location
  • Cost-effective care compared with many Western healthcare systems

Many patients are able to complete evaluation and decision-making within a short visit.


About Dr Shibal Bhartiya

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist with over 25 years of clinical experience. Her work combines clinical care, research, education, and international collaboration.

Highlights include:

  • Fellowship-Trained Glaucoma Specialist
  • Mayo Clinic Research Collaborator
  • 200+ Scientific Publications
  • 90+ PubMed-Indexed Papers
  • 28 Edited Textbooks
  • Editor-in-Chief, CLEVER
  • Executive Editor, Journal of Current Glaucoma Practice
  • International Speaker and Research Collaborator

Languages Spoken

To make complex medical discussions easier for international patients, consultations may be conducted with an interpreter, or facilitator if required. However, Dr Shibal Bhartiya speaks several languages:

  • English
  • Hindi
  • Urdu
  • French
  • Bangla (conversational)
  • Arabic (basic conversational)
  • Persian / Farsi (basic conversational)

Medical records and formal clinical documentation are provided in English, and may be provided in Hindi, French or Urdu on request .


Frequently Asked Questions

Can I send my reports before travelling?

Yes. Sharing reports beforehand helps determine what additional testing may be needed and allows more focused consultations.

Can I obtain a second opinion without surgery?

Absolutely. A large proportion of international patients seek clarity and confirmation before making treatment decisions.

How long should I stay in India?

Most second-opinion evaluations can be completed within 2–3 days. Surgical patients may require longer depending on the procedure.

Will my doctor at home receive a report?

Yes. With your permission, a detailed written opinion can be shared with your treating physician.

Do you assist with medical visa documentation?

Supporting medical documentation can be provided where required.


Send Your Reports Before You Travel

If you are considering travelling to India for glaucoma, neuro-ophthalmology, dry eye treatment, or a specialist second opinion, the process can begin before you leave home.

Send your reports, scans, or questions for review.

Dr Shibal Bhartiya
Glaucoma • Neuro-Ophthalmology • Advanced Eye Care • Second Opinion

🌐 www.drshibalbhartiya.com
📞 +91 88826 38735


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Can Ocular GVHD Cause Dry Eyes?

Ocular GVHD is an eye condition that can develop after bone marrow or stem cell transplant, causing dry eyes, irritation, and fluctuating vision even after the main illness stabilises. Long-term follow-up helps protect the ocular surface, support daily function, and prevent slow, quiet damage from becoming permanent.

Here’s the story of a young girl’s grit and determination, as she battle GVHD. She is now a DOCTOR herself!!


She Came Back Every Holiday

A clinical story about ocular GVHD, dry eyes, and what it means to stay

Some patients stay in your memory because the diagnosis was rare.

Others stay because you realise, years later, that you were not just treating a condition. You were quietly watching somebody become who they were going to be.

I first met her when she was fifteen or sixteen. She had already been through more than most adults carry in a lifetime. She had undergone a bone marrow transplant. And afterwards, she developed ocular graft-versus-host disease — ocular GVHD.

Families who arrive after transplantation carry a particular kind of relief. The worst has happened. Treatment happened. Something enormous has been crossed. But uncertainty travels with them, because the body does not always stop at the finish line of the illness that was treated.

Then the eyes become part of the story.


What Ocular GVHD Feels Like From the Inside

Most people imagine ocular GVHD as something visibly dramatic. Sometimes it is. But for many patients, it arrives quietly.

Dryness that feels like something is always wrong, even on a good day. Burning that begins before the rest of the body feels tired. Vision that stays technically normal but no longer feels effortless.

Reading that becomes work. Studying that becomes slower. Screen time that was once easy and now costs something.

She was fifteen. She was trying to get back to school. She was trying to become a teenager again, the way teenagers are supposed to be — carelessly occupied with the future. And every day, her eyes made that harder.


Managing Ocular GVHD: What Actually Helps

Over the months that followed, we worked through treatment together. We managed her ocular surface carefully. We adjusted care as her symptoms changed. The active ocular GVHD gradually settled. Her vision got better. The comfort improved. Her reading improved. She got back to school.

But as so often happens with ocular GVHD, the story did not simply end when the acute phase resolved. She continued to have dry eyes. Frequent inflammation, sudden flare ups. Good months and difficult ones. The kind of low-grade, persistent vulnerability that does not make headlines but shapes ordinary days.

Steroids, in varying strengths, and frequency; lubricating eyedrops. Her BMT specialist and I, spoke about her thrice a day on some days, and some times, not even once a month.

She lived in Lucknow. Not nearby. And yet she kept coming back. Every few months. Then every holiday. Keeping in touch over the phone. Sometimes, just to talk. And we kept titrating her treatment to her symptoms, and to the disease activity.

Not because something dramatic was happening. Not because her vision was deteriorating. She came because follow-up had quietly become part of how she looked after herself. She understood, at sixteen, what many adults take years to learn: that a condition managed well is a condition you stop noticing.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google


What Patients Actually Remember

Doctors tend to think patients remember the treatment.

Patients usually remember something else. They remember whether someone recognised them the next time they walked in. They remember not having to explain everything from the beginning. They remember the quality of continuity more than the quality of any single intervention.

She sat her Class 12 examinations. Then she prepared for medical entrance exams.

One day she came to see me with her parents. Her eyes were stable. Her vision was good. She had come not because she needed treatment, but because she had received a medical school offer and wanted advice.

Which college. Which city. Whether to go far from home. We sat and talked. Years earlier we had been discussing tear films and corneal staining and drop regimens. Now we were discussing hostels and futures and what she wanted her life to look like.

She chose South India. She started medical school. Her parents were apprehensive because it was far away. Dr Shibal, she said, you can take care of me long distance, can’t you? I gave her a hug.

Your medical college will have an eye doctor, love. Yes, she said, but they’ll not be you.

And she still comes back. Every six months. Every holiday.

At one visit, she smiled and said something I still think about.

My vision is pristine.

I had to pause with that for a moment.

Because I do not think patients become doctors because someone cured them. I think sometimes they become doctors because someone stayed. Because someone showed them, over years of ordinary appointments, what it looks like to pay close attention to a person who is quietly carrying something.


This Is Not a Story About a Perfect Outcome

Her eyes still need looking after. She still struggles in difficult stretches. And is on medication. She still follows up.

But she built a life. She studied. And left home. She entered medicine. And every time she walks back into my clinic, I am reminded that the most important things in practice do not happen in the moments of diagnosis or surgery or crisis.

They happen in the reviews. The adjustments. The small, ordinary appointments where someone walks in and you already know who they are.

That is where medicine actually changes lives.

Last month, she graduated from medical school.


What Is Ocular GVHD?

Ocular graft-versus-host disease (ocular GVHD) is an eye condition that can develop after bone marrow or stem cell transplant. Donor immune cells may attack the tear glands and ocular surface, causing dryness, inflammation, and changes in visual comfort that persist long after the transplant itself has stabilised.

Symptoms can continue, fluctuate, or remain low-grade for years. Because of this, patients often benefit from long-term ophthalmic follow-up even when their systemic illness is well controlled and their measured vision remains good.

Symptoms of Ocular GVHD include:

Dry eyes, burning, irritation, fluctuating vision, redness, light sensitivity, watering, eye fatigue, difficulty reading or using screens for extended periods, and persistent ocular surface sensitivity that worsens with study, work, or environmental change.


How is Ocular GVHD classified?

Acute ocular GVHD develops during or soon after systemic acute GVHD and is characterized by sudden inflammation, redness, pain, tearing, photophobia, and conjunctival involvement.

Chronic ocular GVHD is a long-term immune-mediated disease that typically presents with persistent dry eye, burning, grittiness, fluctuating vision, meibomian gland dysfunction, and progressive ocular surface damage.

Acute-on-chronic ocular GVHD occurs when a patient with established chronic ocular GVHD experiences a sudden inflammatory flare, causing a rapid worsening of symptoms such as redness, pain, light sensitivity, and ocular surface inflammation on top of their baseline chronic dry eye disease.


When Should You See an Eye Specialist?

If you or your child has undergone a bone marrow or stem cell transplant and you notice persistent dryness, redness, fluctuating vision, burning, or discomfort — do not assume this is simply part of recovery.

The ocular surface can remain affected even after systemic disease feels far behind you. Early evaluation may preserve comfort, function, and long-term visual quality.

Known for her structured approach to vision risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.


This page is part of the Dry Eye Disease hub . Read about our full approach to GVHD, Dry Eyes and children’s eye care. Please also read Pediatric Eye Care hub

Here’s another heartening patient story: A young boy and his love for trucks


FAQs:

What is ocular GVHD?

Ocular GVHD is a complication that can develop after bone marrow or stem cell transplant. Donor immune cells affect the tear glands and eye surface, causing dryness, inflammation, and visual discomfort that may persist long after the main transplant illness stabilises.

What are the common symptoms?

Dry eyes, burning, fluctuating vision, redness, irritation, light sensitivity, watering, difficulty reading, and visual fatigue that worsens with screens or study.

Can ocular GVHD improve over time?

Yes. Many patients improve significantly, particularly with consistent treatment and close follow-up. Some continue to experience low-grade dryness or surface sensitivity for years. This does not mean the condition is untreatable — it means it requires sustained attention rather than a single course of treatment.

Can patients with ocular GVHD study, work, and live normally?

Many can, particularly when symptoms are identified early and managed consistently. The goal of treatment is not only to protect vision but to restore the quality of everyday life — reading, screens, study, and all the things that ordinary days are made of.

Why is long-term follow-up important?

Symptoms and underlying ocular surface health do not always change in parallel. A patient may feel stable and still have ongoing surface changes that benefit from monitoring. Regular review allows treatment to be adjusted before problems compound.

Does ocular GVHD affect children and young people differently?

The condition affects children and adolescents at a time when study load, screen use, and daily reading demands are high. Symptoms that an adult might manage around can significantly affect a young person’s academic performance and sense of normalcy. Recognising this early changes what the follow-up plan should look like.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Are steroid eye drops dangerous?

Steroid eye drops prescribed by a doctor are not dangerous. They become dangerous when used without a prescription, unsupervised, or for longer than directed, because they may increase your eye pressure. This puts you at risk for steroid induced glaucoma. But when your doctor prescribes them, the benefit — stopping inflammation, saving vision — outweighs the risk. Avoiding a necessary prescription is where real harm begins, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Steroids in the Eye: When Fear of the Drop Does More Damage

She was a psychiatrist. A trained physician. She understood pharmacology, and she had read about intraocular pressure and steroid response. So when her ophthalmologist prescribed steroid eye drops after an adenoviral conjunctivitis, she quietly decided not to use them.

Three months later, she sat in front of me. A psychiatrist — a trained physician — spent three months losing vision because she was afraid to use a prescribed drop. Here is what that case teaches every patient.

Her vision had dropped to 6/18 in both eyes. Her corneas were covered in superficial punctate keratitis — so dense and widespread it looked almost like numular keratitis. What began as a straightforward viral conjunctivitis had become a prolonged, damaging inflammatory response, because her immune system was never asked to stand down.

She had never had her eye pressure checked, and was not a known steroid responder. She had simply been afraid of a word.

Within three to four days of starting the prescribed drops, she began to improve. Her vision normalised in two weeks. Three months of avoidable suffering — from one decision to skip a prescription. Her pressures remained well within normal limits.

Why the Fear Exists — and the Risk

Steroids raise eye pressure in susceptible individuals. This is true. In long-term, unsupervised use, the kind that happens when people buy steroid drops over the counter, this risk is real and serious. Steroid Induced Glaucoma can cause irreversible vision loss.

But this is not the situation your doctor creates when they hand you a prescription. She will check your eye pressures before starting eye drops, and monitor it through the duration of therapy.

A doctor prescribing steroid drops accounts for:

  • The specific diagnosis — inflammation, allergy, or a post-viral immune response
  • The right steroid molecule and strength for that condition
  • A taper plan, not an open-ended course
  • Pressure monitoring if the course extends beyond the short term

The risk of not using the drops, in the right condition, is often far greater than any monitored, time-limited course.

Important

In India, steroid eye drops can be purchased without a prescription. This does not make it safe. Unsupervised, over-the-counter steroid use is the primary source of steroid-related eye damage: not prescribed, monitored courses. The two situations carry entirely different risk profiles.

To know more about glaucoma, risks and symptoms, you may want to listen to this conversation

VKC in Children: Where Hesitation Costs Sight

Parents of children with vernal keratoconjunctivitis (VKC) frequently arrive distressed at the idea of steroids for their child. The concern is understandable. It is also, when correctly informed, less alarming than the disease itself.

Fluorometholone and loteprednol are approved for children as young as one year in the United States. These are not aggressive systemic steroids. They are targeted molecules with well-established paediatric safety records, prescribed precisely because the risks of the disease exceed the risks of the treatment.

Giant papillary conjunctivitis does not respond to antiallergic drops alone. Corneal shields (or shield ulcers) — the plaques that form in severe VKC — do not respond to cold compresses, and mild anti allergies. The window for preventing permanent corneal damage is not infinite.

In these cases, the right medicine at the right time, under supervision, is the difference between a child who sees normally and one who does not.

Steroid Eye Drops at a Glance

Molecules, indications, risk by scenario, and cost of avoidance — combined reference

Steroid / ScenarioCommon UseApproved AgeSupervised RiskUnsupervised / OTC RiskCost of Avoidance
Steroid Molecules
Prednisolone acetateSevere inflammation, post-surgical, uveitisAdults (caution in children)Moderate
Higher IOP risk; needs monitoring
High
Glaucoma, cataract risk
Corneal scarring, vision loss
Fluorometholone (FML)Allergic conjunctivitis, VKC, mild-moderate inflammation≥ 2 years (US approval)Lower
Reduced IOP penetration
Moderate
Still causes pressure rise if prolonged
Persistent giant papillae, corneal shield
LoteprednolVKC, seasonal allergy, post-surgical≥ 1 year (US approval)Low
Metabolised locally; lowest IOP burden
Moderate
Risk increases with duration
Persistent severe allergy, corneal damage
DexamethasoneSevere ocular inflammation, post-op, uveitisAdults; children under specialist careModerate–High
Strong molecule; close monitoring needed
Very High
Rapid IOP rise possible
Irreversible optic nerve damage if pressure unchecked
Clinical Scenarios
Post-viral keratitis (adenoviral)Subepithelial infiltrates, SPK, vision dropAll agesLow–Moderate
Short course, tapered
High
Prolonged use → pressure crisis
Persistent SPKs, 6/18 or worse vision — as seen in case above
VKC (children)Giant papillae, shield ulcer risk, corneal involvementAs young as 1 year with appropriate moleculeLow
With loteprednol / FML and monitoring
High
Inappropriate molecule + no monitoring
Corneal shield ulcer, permanent visual impairment
Giant papillary conjunctivitisSevere allergic response, contact lens–relatedAdults and older childrenLow–Moderate
Under supervision
ModerateNo response to antiallergics alone; chronic discomfort, corneal involvement
Use Pattern Risk
Prescribed short course (7–14 days, tapered)Any indicated conditionLowN/A — by definition supervisedAvoidance causes disease progression
OTC self-medication, IndiaOften misused for red eye, irritationN/AVery High
No diagnosis, no taper, no monitoring
Steroid-induced glaucoma, cataract — often irreversible

What You Should — and Should Not — Do

Use steroid eye drops when your doctor prescribes them. Follow the taper exactly. Do not stop abruptly. Have your pressure checked if your doctor asks. Do not extend the course on your own judgment.

Do not buy steroid eye drops from a pharmacy without a prescription. In India, this is possible. It is also the origin of most steroid-related eye complications seen in clinical practice — not prescribed, monitored use.

Frequently Asked Questions

Can steroid eye drops damage my eyes?

Steroid eye drops used without medical supervision, and for longer than prescribed, can raise eye pressure, cause cataracts, and increase infection risk. Prescribed, monitored courses carry a very different risk profile. The damage in most cases comes from unsupervised, over-the-counter use — not from following a doctor’s prescription.

Why did my doctor prescribe steroid drops after conjunctivitis?

After viral conjunctivitis — particularly adenoviral — the eye can mount a prolonged inflammatory response even after the infection clears. Steroid drops are prescribed to control this immune response and protect the cornea. Skipping them does not protect you. It leaves the inflammation unchecked.

Are steroid eye drops safe for children with VKC?

Specific steroid molecules — fluorometholone, loteprednol — are approved for use in young children and have an established paediatric safety record. In vernal keratoconjunctivitis, the risk of corneal damage from untreated disease is often greater than the risk from a supervised steroid course.

Can I buy steroid eye drops without a prescription in India?

Unscrupulous pharmacies in India dispense them without a prescription. This does not mean it is safe. Unsupervised steroid use is the primary cause of steroid-related eye complications. Always use them under a doctor’s direction.

What is a steroid responder?

Some individuals — roughly 5% of the population — show a significant rise in eye pressure in response to steroid drops. This is a genetic predisposition. It does not mean everyone should avoid steroids; it means a doctor prescribing steroids should check your pressure during use, particularly if the course extends beyond two weeks.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Optic Nerve Cupping: What Does It Mean When Your Doctor Says Your Cup Is Large?

Optic nerve cupping refers to the size of the central hollow, the cup, within the optic disc at the back of your eye. A large cup does not automatically mean glaucoma, but it is one of the most important findings an eye doctor can make, and it always warrants a thorough explanation.

If you have been told your cup-to-disc ratio is large, or that your optic nerve looks suspicious, this article explains exactly what that means and what happens next.


Understanding the Optic Disc and the Cup

The optic disc is the point where the optic nerve exits the eye, visible as a small, pale, circular structure at the back of the retina. Within this disc is a central depression called the cup. The rim of neural tissue surrounding the cup, the neuroretinal rim, contains the nerve fibres that carry visual information from the retina to the brain.

The cup-to-disc ratio (CDR) describes the size of the cup relative to the overall disc. A CDR of 0.3 means the cup occupies 30 percent of the disc diameter. A CDR of 0.7 means the cup occupies 70 percent.

Normal CDR values vary widely in the population. Most people have a CDR between 0.1 and 0.5. A CDR above 0.6 is considered large and warrants assessment, though it is not in itself a diagnosis. What matters is not just the size of the cup, but the thickness and health of the rim surrounding it.


Why Cupping Happens

Physiological cupping — large but healthy Many people are simply born with a large optic disc and a correspondingly large cup. In these individuals, the neuroretinal rim is intact, the cup has a regular shape, and there is no evidence of nerve fibre loss on OCT or visual field testing. This is called physiological cupping. It requires monitoring, because a large cup makes subtle glaucomatous changes harder to detect, but it is not a disease.

Glaucomatous cupping — the cup enlarging over time In glaucoma, the elevated intraocular pressure damages and kills the nerve fibres in the neuroretinal rim. As fibres are lost, the rim thins and the cup expands, the process called cupping progression. The cup does not just become larger; it changes shape. The rim becomes notched, particularly at the superior and inferior poles where glaucoma tends to strike earliest. The blood vessels at the disc margin may be pushed to one side, a finding called bayoneting, and small haemorrhages may appear at the disc margin.

Glaucomatous cupping is permanent. The nerve fibres that are lost do not return. This is why early detection and pressure control, before significant cupping occurs, is the entire goal of glaucoma management.

Other causes of cupping Non-glaucomatous optic neuropathies can cause cupping that superficially resembles glaucomatous damage. Anterior ischaemic optic neuropathy, a stroke of the optic nerve, can produce cupping with a characteristic pattern of visual field loss. Compressive lesions behind the eye, tumours pressing on the optic nerve or chiasm, can also cause the cup to appear enlarged as nerve tissue is lost. This is one reason a suspicious optic disc always prompts a full assessment rather than an assumption of glaucoma.


What a Large CDR Means in Practice

Being told you have a large cup-to-disc ratio is the beginning of a clinical question, not the end of one. The question is: is this cup large because you were born that way, or because nerve tissue has been lost?

Answering this question requires:

Intraocular pressure measurement: to assess whether pressure is elevated and contributing to nerve damage.

OCT of the optic nerve and retinal nerve fibre layer (RNFL): to measure the actual thickness of the nerve tissue surrounding the cup. OCT can detect thinning before it is visible clinically or before it affects the visual field. A large cup with normal OCT thickness is reassuring. A large cup with thinned RNFL is a significant finding.

Visual field testing: to determine whether the nerve damage, if any, has translated into measurable loss of peripheral vision.

Gonioscopy: Examination of the drainage angle of the eye to assess the type of glaucoma. And to assess whether the angle is open or narrow.

Disc photography or OCT disc imaging: to document the current appearance and establish a baseline for future comparison. Change over time is often more meaningful than a single measurement.

Central corneal thickness: because a thin cornea gives falsely low pressure readings. A patient with a large cup and a thin cornea has a higher true IOP burden than the measured number suggests.


The Cup-to-Disc Ratio Is Not the Whole Story

Experienced glaucoma specialists look beyond the CDR number at several disc features that carry independent diagnostic weight:

Rim thinning — the neuroretinal rim should be thickest at the inferior and superior poles (following the ISNT rule: Inferior > Superior > Nasal > Temporal). Reversal of this pattern, particularly inferior or superior notching, is a red flag regardless of the overall CDR.

Disc haemorrhages — a small splinter-shaped bleed at the disc margin is one of the strongest single predictors of glaucoma progression. It is easily missed on a quick fundus examination and requires careful, dilated disc inspection to detect.

Peripapillary atrophy (PPA) — a zone of pale, thinned retina around the optic disc. Beta-zone PPA, adjacent to the disc, is associated with glaucoma and with areas of RNFL thinning. Its presence and extent add diagnostic information.

Vessel position and bayoneting — Displacement of vessels to the nasal side of the disc as the cup expands is a clinical sign of significant cupping.

Asymmetry between the two eyes — A CDR difference of 0.2 or more between the two eyes is clinically significant even if both values appear within normal limits individually. The eyes should be symmetric; asymmetry raises suspicion.


What Doctors Often Miss Telling You

  • A large CDR in one examination is a starting point, not a conclusion. The most important question is whether it is the same as last year, or larger. Without a baseline photograph or OCT, it is impossible to know. If you have never had disc imaging, ask for it.
  • Disc haemorrhages are transient and easily missed. They disappear within six to twelve weeks. A patient who has a haemorrhage between appointments may never have it documented unless the timing is right. If you notice a sudden change in your vision between appointments, attend sooner.
  • Physiological large cups run in families. If your parent or sibling has been told they have a large cup and investigated thoroughly, and found to be normal, your large cup is more likely physiological. But it still requires proper documentation.
  • You can have glaucoma with a normal CDR. Normal-tension glaucoma, is a type of glaucoma where pressure is within the statistically normal range. It is defined by optic nerve damage and visual field loss despite a pressure that would not be flagged as elevated. The disc changes are real; the pressure number is misleading. A normal IOP does not rule out glaucoma.
  • Race affects optic disc size. People of African descent tend to have larger optic discs, and therefore larger physiological cups, than people of European or Asian descent. A CDR of 0.7 in a Black patient may be completely physiological. However, the same value in a patient of East Asian descent warrants more careful scrutiny. Normative databases used in OCT analysis are population-specific for this reason.

When to Worry

Seek assessment promptly, ideally within days, not weeks, if you notice:

  • A new area of missing or dim vision in any part of your visual field
  • Blurring that is worse in one eye than the other and was not present before
  • A shadow, curtain, or arc of darkness at the edge of your vision
  • A sudden change in colour perception in one eye
  • You have been told in the past that your optic nerve looks suspicious but have never had a full glaucoma workup including OCT and visual fields

If your large cup has never been formally investigated with IOP, OCT, and visual field testing, that assessment is overdue regardless of how long ago you were told about it.


Frequently Asked Questions

What is a normal cup-to-disc ratio?

Most people have a cup-to-disc ratio between 0.1 and 0.5. A CDR above 0.6 is considered large and warrants assessment, though it is not automatically abnormal. What matters is the health of the surrounding neuroretinal rim, the OCT thickness, and the visual field, not the CDR number alone.

Does a large cup-to-disc ratio mean I have glaucoma?

Not necessarily. A large cup can be physiological, simply part of your normal anatomy, or it can indicate glaucomatous damage. Distinguishing between the two requires a full assessment including IOP, OCT, visual field testing, and disc imaging. A single number does not make a diagnosis.

Can optic nerve cupping be reversed?

Glaucomatous cupping, caused by irreversible nerve fibre loss, cannot be reversed. Lowering intraocular pressure stops further damage but does not restore what has already been lost. Some apparent reversal of cupping has been reported in infants and young children after IOP reduction, but this is not observed reliably in adults.

How is optic nerve cupping monitored?

Serial OCT scans of the optic nerve head and retinal nerve fibre layer, combined with visual field testing, are the standard monitoring tools. Disc photographs provide a qualitative record. The goal is to detect any progressive thinning of the neuroretinal rim or worsening of the visual field before vision loss becomes symptomatic.

Can I have a large cup and never develop glaucoma?

Yes. Many people with large physiological cups live their entire lives without developing glaucoma. The cup requires monitoring, ideally with baseline OCT and periodic review, but large cup size alone does not predict disease. The risk is that subtle early glaucomatous changes are harder to detect against the background of an already-large cup. This is why careful long-term follow-up is important.

What is the difference between a large cup and glaucoma?

Glaucoma is a disease of progressive optic nerve damage, defined by characteristic structural changes (thinning of the neuroretinal rim, RNFL loss) combined with corresponding functional changes (visual field defects). A large cup-to-disc ratio is an anatomical observation. Glaucoma requires evidence of damage and, in most cases, a pressure that is too high for that particular optic nerve. The two frequently overlap, but they are not the same thing.


Speak to a Specialist

If you have been told your cup is large, your optic nerve looks suspicious, or your CDR has changed, and you have not had a complete glaucoma workup, that assessment is the right next step. A large cup investigated thoroughly and found to be healthy is genuinely reassuring. A large cup that turns out to be early glaucoma, caught before the visual field is affected, is a vision-saving finding.

Book a consultation: +91 88826 38735 | www.drshibalbhartiya.com

Upload your OCT reports, disc photographs, and visual field results through the website before your appointment.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

PubMed Profile | Google Scholar | ResearchGate | ORCID

Helped by this article? Leave a Google review — it helps other patients find reliable eye care.

📋 Upload your reports for review before your appointment at www.drshibalbhartiya.com

📞 +91 88826 38735

OCT Normal But Vision Symptoms Persist

A normal eye scan does not always explain real-world visual symptoms. Persistent blur, reading fatigue, low-light difficulty, contrast loss, or visual discomfort may need deeper functional and clinical evaluation.

Seeing clearly on tests is not always the same as seeing comfortably in life. When symptoms persist despite normal OCT findings, the next step may be understanding how your eyes and visual system function—not just how they look, Dr Shibal Bhartiya explains.

My OCT Is Normal — So Why Does Vision Still Feel Wrong?

You came in with a symptom. You left with a normal report. And yet something is still not right.

That gap — between what tests show and what you feel — is one of the most common reasons patients seek a second opinion. It is also one of the most undertreated problems in eye care.

If your OCT is normal but your vision feels blurred, dim, or unreliable, this article explains what may be happening, what else needs to be checked, and what you should ask your doctor next.


The short answer

A normal OCT does not mean your eyes are healthy. It means the test did not detect structural damage at the time it was taken. OCT measures the thickness of retinal layers and the optic nerve fibre layer. It cannot measure how well those cells are functioning, how signals travel to the brain, or how your visual cortex processes what it receives.

Vision is not a photograph. It is a continuous biological process — and that process can fail at many points that OCT simply cannot see.


What OCT actually measures — and what it misses

OCT (Optical Coherence Tomography) creates a cross-sectional image of retinal tissue. It is excellent at detecting structural thinning, fluid, and anatomical changes.

It does not measure:

  • Nerve fibre function (only structure)
  • Signal transmission speed from eye to brain
  • Brain processing of visual information
  • Dynamic contrast sensitivity
  • Early functional loss before structural change occurs

This is the key clinical reality: functional loss can precede structural loss. A normal OCT early in the disease does not rule out damage — it rules out visible damage.


Why your vision symptoms may be real even with a normal OCT

SymptomPossible explanationTest OCT misses
Blurred vision, tests normalDry eye, early corneal irregularity, refractive instabilityCorneal topography, tear film assessment
Dim or washed-out visionContrast sensitivity loss, early optic neuropathyContrast sensitivity testing, VEP
Peripheral vision lossPre-perimetric glaucoma, neurological causeVisual field test, MRI
Fluctuating visionIntraocular pressure spikes, diabetes-related changes24-hour IOP monitoring, HbA1c
Vision worse at nightEarly rod photoreceptor dysfunction, vitamin A deficiencyERG, dark adaptometry
Double visionBinocular misalignment, cranial nerve palsyOrthoptic assessment, neuroimaging
Colour desaturationOptic neuritis, nutritional optic neuropathyColour vision testing, MRI of optic nerves

What we often miss

1. The structure-function gap in glaucoma OCT can be normal in early glaucoma. If you have a family history, high IOP, thin corneas, or disc suspicion, a normal OCT does not close the investigation. Visual field testing and longitudinal OCT comparison matter more than a single normal scan.

2. Dry eye causing real blur Tear film instability creates optical aberrations that no retinal scan captures. Patients with significant dry eye can have 20/20 Snellen acuity on a chart and genuinely blurred functional vision in daily life. This is not imagined — it is a real, measurable phenomenon on corneal topography and tear film assessment.

3. Contrast sensitivity loss Standard visual acuity testing uses high-contrast black letters on white backgrounds. Functional vision operates in low-contrast environments — faces, steps, road markings at dusk. Contrast sensitivity can be significantly reduced with a perfectly normal Snellen chart and a normal OCT. It is almost never tested in a standard eye examination.

4. Optic neuritis and demyelinating disease Early optic neuritis — inflammation of the optic nerve — can cause colour desaturation, pain on eye movement, and mild vision loss before OCT shows nerve fibre thinning. In retrobulbar neuritis, the OCT and eye examination are often normal. Just the pupils may be affected. The diagnosis is clinical and confirmed with MRI, not OCT.

5. Functional visual disturbance Some patients have genuine visual symptoms originating in the visual cortex or processing pathways rather than the eye itself. Migraine aura, cortical spreading depression, and posterior cortical atrophy all produce visual symptoms with entirely normal eye examinations. These require neurological evaluation.

6. Nutritional optic neuropathy Vitamin B12 deficiency, folate deficiency, and toxic exposures (including some medications) can produce progressive vision loss that appears structurally normal on OCT for months before thinning is detectable. Colour vision testing and a detailed history are the first clue.


The clinical principle that changes everything

In medicine, the absence of a finding on one test is not the same as the absence of disease.

OCT is one tool. It has a detection threshold. Below that threshold, it reports normal — and genuine pathology exists. Good clinical judgment means combining the test result with the symptom history, risk profile, and the full clinical picture.

A patient who says “something feels wrong” and has a normal OCT has not been cleared. They have had one test, which found nothing on that day, using that technology, at that stage of their condition.


When you should seek a second opinion

Seek a specialist review if:

  • You have persistent visual symptoms and have been told “tests are normal”
  • You have a family history of glaucoma, macular degeneration, or optic nerve disease
  • Your symptoms affect daily function — driving, reading, night vision — even if your Snellen acuity is normal
  • You have been given a diagnosis that does not fully explain your experience
  • You have systemic conditions including diabetes, hypertension, autoimmune disease, or a neurological history
  • Your symptoms are progressing, even slowly

A second opinion is not a reflection on your current doctor. It is appropriate care when symptoms persist without resolution.


What a thorough evaluation includes beyond OCT

A complete workup for unexplained vision symptoms may include some of these tests:

  • Visual field testing (perimetry) — functional, not structural
  • Contrast sensitivity testing — functional vision in real-world conditions
  • Corneal topography and tear film assessment — for optical surface irregularity
  • 24-hour IOP monitoring — for pressure spikes missed in clinic
  • Visual Evoked Potentials (VEP) — signal transmission from eye to brain
  • Electroretinogram (ERG) — photoreceptor function
  • MRI of the brain and optic nerves — when neurological cause is possible
  • Colour vision testing — early optic nerve dysfunction
  • Blood tests — B12, folate, HbA1c, autoimmune markers, thyroid function

FAQ

Can glaucoma be missed on a normal OCT?

Yes. In early glaucoma structural changes on OCT may not yet be detectable, even when functional damage has begun. This is why clinical context, risk factors, and longitudinal monitoring matter alongside any single test result.

What does it mean if my vision is blurry but my eye test is normal?

It means the standard test did not identify a cause — not that no cause exists. Dry eye, contrast sensitivity loss, early optic nerve dysfunction, and neurological causes can all produce real blur with a normal standard examination. Further testing is appropriate.

My doctor said everything is fine but I still have symptoms. What should I do?

Ask for a more detailed explanation of which tests were done and what they measure. If your symptoms persist or affect your daily life, a second specialist opinion is reasonable and appropriate.

Is a normal OCT enough to rule out glaucoma?

Not on its own. OCT is one part of a glaucoma assessment. Clinical history, intraocular pressure pattern, corneal thickness, optic disc appearance, family history, and visual field results all contribute to the complete picture. A single normal OCT in a high-risk individual does not close the diagnosis.

Can dry eye cause vision symptoms with a normal OCT?

Yes. Tear film instability creates real optical blur that OCT does not capture. If your OCT and retinal examination are normal and you have persistent blur — especially variable blur that improves on blinking — dry eye deserves careful investigation.

When does a normal eye test mean something is happening in the brain?

If your eye examination is entirely normal — including the tear film and cornea, OCT, visual fields, and optic nerve — but visual symptoms persist, neurological evaluation is appropriate. Conditions including migraine, demyelinating disease, and cortical visual processing disorders produce genuine symptoms originating beyond the eye itself.


What you can do now

If your OCT is normal but symptoms persist, write down the following before your next appointment:

  1. Exactly what you experience — blur, dimness, distortion, peripheral loss, fluctuation
  2. When it is worst — morning, evening, certain distances, particular lighting
  3. How long it has been present and whether it is changing
  4. Any systemic conditions, medications, or family history of eye disease

This history is often the most important diagnostic information available. Tests answer the questions doctors think to ask. Your symptoms tell a broader story.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google